申请人:Incyte Corporation
公开号:US20170158710A1
公开(公告)日:2017-06-08
The present disclosure relates to tricyclic heterocycles which are inhibitors of BET proteins such as BRD2, BRD3, BRD4, and BRD-t and are useful in the treatment of diseases such as cancer.